| Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease (NCT00448201) | UNC Lineberger Comprehensive Cancer Center | 2011-01-07 |
| Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant (NCT01118013) | Alliance for Clinical Trials in Oncology | 2010-12-01 |
| Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00568880) | Abramson Cancer Center at Penn Medicine | 2010-09-08 |
| Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation (NCT01116232) | Barbara Ann Karmanos Cancer Institute | 2010-08-01 |
| Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer (NCT01164709) | Swiss Cancer Institute | 2010-07-01 |
| Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome (NCT00946283) | Rutgers, The State University of New Jersey | 2010-03-01 |
| Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant (NCT01077440) | Vanderbilt University | 2010-02-01 |
| Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma (NCT00942422) | Barbara Ann Karmanos Cancer Institute | 2009-11-01 |
| Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation (NCT00996359) | University of Medicine and Dentistry of New Jersey | 2009-10-01 |
| Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma (NCT00938626) | Barbara Ann Karmanos Cancer Institute | 2009-10-01 |
| 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer (NCT00935090) | Barbara Ann Karmanos Cancer Institute | 2009-09-01 |
| Registry of Older Patients With Cancer (NCT01137825) | UNC Lineberger Comprehensive Cancer Center | 2009-09-01 |
| Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma (NCT00962507) | City of Hope Medical Center | 2009-07-01 |
| Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer (NCT01137643) | UNC Lineberger Comprehensive Cancer Center | 2009-07-01 |
| Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma (NCT00941720) | Case Comprehensive Cancer Center | 2009-06-11 |
| Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer (NCT00726830) | M.D. Anderson Cancer Center | 2009-03-01 |
| Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer (NCT00823524) | Asan Medical Center | 2009-01-01 |
| Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment (NCT00800150) | City of Hope Medical Center | 2008-11-01 |
| Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers (NCT00952185) | City of Hope Medical Center | 2008-11-01 |
| American Ginseng in Treating Patients With Fatigue Caused by Cancer (NCT00719563) | Alliance for Clinical Trials in Oncology | 2008-10-01 |
| Vorinostat, Bortezomib, and Doxorubicin Hydrochloride Liposome in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00744354) | UNC Lineberger Comprehensive Cancer Center | 2008-10-01 |
| Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder (NCT00755040) | Vanderbilt-Ingram Cancer Center | 2008-10-01 |
| Sorafenib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00687674) | Mayo Clinic | 2008-08-01 |
| Blood Samples From Patients on a Clinical Trial to CINV During HSCT (NCT00900068) | OHSU Knight Cancer Institute | 2008-08-01 |
| Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide (NCT00899080) | Eastern Cooperative Oncology Group | 2008-07-04 |
| Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma (NCT00742404) | Oncotherapeutics | 2008-07-01 |
| Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant (NCT00725062) | Masonic Cancer Center, University of Minnesota | 2008-06-01 |
| Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases (NCT00813501) | City of Hope Medical Center | 2008-06-01 |
| Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma (NCT00635024) | Mayo Clinic | 2008-05-01 |
| Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers (NCT00770419) | Rutgers, The State University of New Jersey | 2008-05-01 |
| High-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With Relapsed Multiple Myeloma After Chemotherapy (NCT00747877) | Leeds Cancer Centre at St. James's University Hospital | 2008-04-01 |
| Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial (NCT00750009) | Case Comprehensive Cancer Center | 2008-04-01 |
| Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer (NCT00918658) | Case Comprehensive Cancer Center | 2008-04-01 |
| Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer (NCT00516503) | Alliance for Clinical Trials in Oncology | 2008-02-01 |
| Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma (NCT00792142) | City of Hope Medical Center | 2008-01-16 |
| Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders (NCT00740467) | Institut Paoli-Calmettes | 2008-01-01 |
| Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant (NCT00513474) | Massachusetts General Hospital | 2008-01-01 |
| Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma (NCT00569309) | Ohio State University Comprehensive Cancer Center | 2007-12-12 |
| Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis (NCT00564889) | Mayo Clinic | 2007-12-01 |
| High-Dose Melphalan With or Without Radiolabeled Monoclonal Antibody in Treating Patients With Multiple Myeloma Undergoing an Autologous Stem Cell Transplant (NCT00637767) | University of Southampton | 2007-12-01 |
| Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma (NCT00566098) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-11-01 |
| CC-4047 and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Amyloidosis (NCT00558896) | Mayo Clinic | 2007-11-01 |
| Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma (NCT00567229) | Memorial Sloan Kettering Cancer Center | 2007-11-01 |
| Studying Fentanyl in Patients With Cancer (NCT00899951) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-10-01 |
| Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple Myeloma (NCT00470093) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-10-01 |
| Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma (NCT00474929) | Mayo Clinic | 2007-08-29 |
| Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer (NCT00499668) | Vanderbilt-Ingram Cancer Center | 2007-08-01 |
| Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant (NCT00602446) | Masonic Cancer Center, University of Minnesota | 2007-08-01 |
| Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose Melphalan (NCT00602147) | Vanderbilt-Ingram Cancer Center | 2007-07-01 |
| Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers (NCT00619645) | University of California, Davis | 2007-06-01 |
| Bortezomib, Arsenic Trioxide, and Melphalan in Treating Patients Undergoing an Autologous Stem Cell Transplant For Multiple Myeloma (NCT00504101) | University of Miami | 2007-06-01 |
| Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy (NCT00416624) | Mayo Clinic | 2007-05-01 |
| Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer (NCT00589563) | City of Hope Medical Center | 2007-05-01 |
| Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases (NCT00376519) | Masonic Cancer Center, University of Minnesota | 2007-05-01 |
| Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer (NCT00787761) | Northside Hospital, Inc. | 2007-04-01 |
| Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant (NCT00469820) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-04-01 |
| Fludarabine, Busulfan, Antithymocyte Globulin, and Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma That Has Not Responded to Treatment (NCT00802568) | Institut Paoli-Calmettes | 2007-04-01 |
| Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer (NCT00806767) | Institut Paoli-Calmettes | 2007-03-01 |
| Melphalan and Autologous Stem Cell Transplant Followed By Bortezomib and Dexamethasone in Treating Patients With Previously Untreated Systemic Amyloidosis (NCT00458822) | Memorial Sloan Kettering Cancer Center | 2007-02-01 |
| Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases (NCT00453206) | Wake Forest University Health Sciences | 2007-02-01 |
| Lenalidomide and Vaccine Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00445484) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-01-01 |
| Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases (NCT00424242) | Northwestern University | 2007-01-01 |
| Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant (NCT00900406) | Vanderbilt-Ingram Cancer Center | 2007-01-01 |
| Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant (NCT00964821) | City of Hope Medical Center | 2007-01-01 |
| Stem Cell Transplant, Chemotherapy, and Biological Therapy in Treating Patients With High-Risk or Refractory Multiple Myeloma (NCT00499577) | University of Maryland Greenebaum Cancer Center | 2006-12-01 |
| T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant (NCT00651716) | Vanderbilt-Ingram Cancer Center | 2006-12-01 |
| Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma (NCT00609167) | Mayo Clinic | 2006-12-01 |
| Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma (NCT00458705) | Memorial Sloan Kettering Cancer Center | 2006-11-01 |
| Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma (NCT00438841) | Fred Hutchinson Cancer Center | 2006-08-01 |
| Study of DNA Samples From Patients With Multiple Myeloma (NCT00898040) | ECOG-ACRIN Cancer Research Group | 2006-07-06 |
| Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma (NCT00478218) | Mayo Clinic | 2006-07-01 |
| Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant (NCT00410657) | Fred Hutchinson Cancer Center | 2006-07-01 |
| Bortezomib, Doxorubicin Hydrochloride Liposome, and Thalidomide as First-line Therapy in Treating Patients With Previously Untreated Stage I, II, or III Multiple Myeloma (NCT00523848) | Roswell Park Cancer Institute | 2006-06-01 |
| Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases (NCT00376922) | Wake Forest University Health Sciences | 2006-06-01 |
| Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer (NCT00827099) | Northside Hospital, Inc. | 2006-06-01 |
| Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00085449) | Alliance for Clinical Trials in Oncology | 2006-05-01 |
| Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant (NCT00324324) | OHSU Knight Cancer Institute | 2006-05-01 |
| Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00482495) | Mayo Clinic | 2006-04-01 |
| Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma (NCT00317798) | University of Rochester | 2006-04-01 |
| Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma (NCT00305812) | NCIC Clinical Trials Group | 2006-03-09 |
| Bortezomib and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Has Not Responded to Treatment (NCT00389701) | Sparrow Regional Cancer Center | 2006-03-01 |
| Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant (NCT00281814) | The Cleveland Clinic | 2006-02-01 |
| Doxorubicin Hydrochloride Liposome, Melphalan, and Bortezomib in Treating Patients With Relapsed or Refractory Stage I, Stage II, or Stage III Multiple Myeloma (NCT00334932) | Herbert Irving Comprehensive Cancer Center | 2006-02-01 |
| Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation (NCT00281801) | Case Comprehensive Cancer Center | 2006-02-01 |
| High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma (NCT00526734) | Erasme University Hospital | 2006-02-01 |
| Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer (NCT00281879) | OHSU Knight Cancer Institute | 2006-02-01 |
| Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer (NCT00661999) | Mayo Clinic | 2006-01-01 |
| Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00316940) | Oncotherapeutics | 2005-12-01 |
| PAD. ICORG 05-01, V11 (NCT00814541) | Cancer Trials Ireland | 2005-12-01 |
| Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease (NCT00719849) | Fred Hutchinson Cancer Center | 2005-11-01 |
| Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma (NCT00317811) | Oncotherapeutics | 2005-11-01 |
| Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma (NCT00378768) | Fred Hutchinson Cancer Center | 2005-11-01 |
| Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen (NCT00448357) | UNC Lineberger Comprehensive Cancer Center | 2005-10-01 |
| Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis (NCT00477971) | Mayo Clinic | 2005-10-01 |
| Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil (NCT00608517) | Vanderbilt-Ingram Cancer Center | 2005-09-01 |
| Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple Myeloma (NCT00313625) | Fred Hutchinson Cancer Center | 2005-09-01 |
| Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00478075) | Mayo Clinic | 2005-09-01 |
| A Standardized Nursing Intervention Protocol for HCT Patients (NCT00951626) | City of Hope Medical Center | 2005-09-01 |
| S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease (NCT00898066) | SWOG Cancer Research Network | 2005-09-01 |
| Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer (NCT00255749) | Jonsson Comprehensive Cancer Center | 2005-08-01 |